COVID-19 epidemiology update Download page in .pdf format
Summary of COVID-19 cases, hospitalizations and deaths, testing and variants of concern across Canada and over time.
Current update
Updated:
This summary of COVID-19 cases across Canada contains detailed data about the spread of the virus over time and in different regions of the country. Includes breakdowns by age and sex or gender. Provides an overview of testing, variants of concern, cases following vaccination and severe illness and outcomes.
Update schedule : We update all sections of this page every Friday, except for 'Cases following vaccination', which we update on Tuesdays.
Changes to update schedule
On June 10, 2022, we changed this page to reflect current reporting by the provinces and territories. We’ve switched from daily to weekly updates for cases, deaths and laboratory tests in the following sections: Key updates, Current situation and National overview.
Canada Day: The regular weekly update schedule will resume on Monday, July 4, 2022.
On this page
Key COVID-19 updates (Last data update )
Notes
Key COVID-19 updates: Text description
| Weekly change in cases | {Weekly cases} |
|---|---|
| Total cases | {Total cases} |
| Weekly change in deaths | {Weekly deaths} |
| Total deaths | {Total deaths} |
| Total tests performed | {Tests performed today} |
| Daily percent positive (last 7 days) | {Daily percent positive (last 7 days)} % |
| Daily tests per 100,000 population (last 7 days) | {Rate tests} |
Current situation
Figure 1a. of of COVID-19, (Last data update )
Hover over or tap regions to see cases , and deaths and tests performed in Canada over time. Click the play button to animate the map. Map data is available in .csv and .json formats and data dictionaries for cases and deaths .csv and for lab indicators .csv .
Notes
Figure 1a: Text description
| Location | Total cases | Cases (latest week) | Cases (latest 2 weeks) | Total deaths | Deaths (latest week) | Deaths (latest 2 weeks) | Total tests performed | Moving average daily tests performed (latest week) | Moving average daily percent positivity (latest week) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Count | Rate * | Count | Rate * | Count | Rate * | Count | Rate * | Count | Rate * | Count | Rate * | Count | Count | Rate * | Percent | |
- * Rate per 100,000 population
- Out of the total number of people tested, 76 were repatriated travellers, of which 13 were cases.
| Province | Health Region | Total cases | Cases last 14 days | Total deaths | Deaths last 14 days | ||||
|---|---|---|---|---|---|---|---|---|---|
| Count | Rate * | Count | Rate * | Count | Rate * | Count | Rate * | ||
‡ No data is available for this day, and so the most recently available data is displayed.
† Rate per 1,000,000 population
* Rate per 100,000 population
Note: Out of the total number of people tested, 76 were repatriated travellers, of which 13 were cases.
Figure 1b. of of COVID-19 in Canada (Last data update )
The figures below show cases over time. The range of dates (January 31st, 2020 - present date) is the same for each figure. This allows you to compare the provinces and territories on the same timescale.
Notes
Figure 1b: Text description
National overview
There have been (Num tests} COVID-19 tests performed in Canada or 1,620,777 tests per 1 million people .
| Location | Cases | Deaths | Tests performed |
|---|
Notes
- * Weekly change in cases, deaths and tests performed reflect the changes in the case and death counts between the end of the latest week and the end of the previous week. Data are updated on an ongoing basis. The current report reflects data most recently received by PHAC at the time of the last update and are subject to change.
- N/A means that no update was provided by the province or territory for the latest week.
- Due to changes in COVID-19 testing policies in many jurisdictions since December 2021, case counts are under-estimated.
- Starting April 7, 2022, British Columbia reports all deaths within 30 days of a positive COVID-19 test, regardless of the cause of death. As a result, deaths are now over-estimated for BC and should not be directly compared to other jurisdictions or to earlier data from BC.
COVID-19 variants in Canada
All viruses, including COVID-19, change over time. These changes are called mutations, and result in variants of the virus. Not all mutations are of concern. Most do not cause more severe illness. However, some mutations result in variants of concern or variants of interest.
A variant of concern has mutations that are significant to public health. Before a variant of interest is considered one of concern, scientists and public health professionals must determine if the mutations result in an actual change in the behaviour of the virus. For example, it might:
- spread more easily
- cause more severe illness
- require different treatments, or
- reduce vaccine effectiveness
There are several variants of interest that have mutations similar to variants of concern, but we don’t yet know if they pose a higher risk to public health.
The Public Health Agency of Canada (PHAC) works with provincial and territorial partners and the Canadian COVID-19 Genomics Network (CanCOGeN) to sequence a percentage of all positive COVID-19 test results. Sequencing reveals the genetic code of the virus, which tells us which variant is involved in a specific case of COVID-19. We report the proportion of COVID-19 variants in Canada every week.
We collect evidence to determine if new variants meet the definition for a variant of concern or a variant of interest . Many variants are being tracked across Canada and around the world. Variants of concern now represent a majority of COVID-19 cases in Canada.
Current variants of concern in Canada include:
- Alpha (B.1.1.7)
- Beta (B.1.351)
- Gamma (P.1)
- Delta (B.1.617.2)
- Omicron (B.1.1.529)
New variants will continue to appear. We must remain vigilant and take all available measures to limit spread.
Figure 2. Weekly variant breakdown Updated: December 31, 2021 , 4 pm EDT download weekly variant breakdown data in .csv format
The graphic shows the percentage mix of COVID-19 variants detected in Canada through whole genome sequencing, by week of sample collection. You can see the numbers for each date by hovering over, tabbing to, or long-pressing any of the bars. To see a specific variant or variant grouping, click or press return. Repeat to restore the complete graph. Sublineages or offshoots for some variants can be revealed or hidden by clicking on the name of the variant in the legend.
This information is based on whole genome sequencing from surveillance testing in all provinces and territories. In addition to sequencing done by the National Microbiology Laboratory in Winnipeg, data is included from provincial and territorial laboratories .
Sequencing takes from 1 to 3 weeks to complete, so the proportions for recent weeks may change as more data are added. Surveillance in each province or territory is organized and prioritized according to local needs and may change from time to time. Because of differences in local sampling and reporting, the percentages illustrate trends rather than precise measurements.
Weekly variant breakdown
Percentage of COVID-19 cases identified through whole genome sequencing, presented by variant and by week of sample collection.
Figure 2: Text description
| Variant Grouping |
|---|
Note : The shaded columns on the right represent a period of accumulating data.
Contributing laboratories:
- National Microbiology Laboratory (NML) - supplemental sequencing for all provinces and territories
Detailed case information
The tables and figures below reflect detailed case information provided to the Public Health Agency of Canada (PHAC) by health authorities in the provinces and territories. This data is updated every week. It may change as we get more information about cases.
Updated: June 25, 2021, 9 am EST
Epidemic curve
As of June 25, 2021, 9 am EST , PHAC has received detailed case report data on cases.
The shaded area on the far right of Figure 3 represents a period of accumulating data. This is the period of time (1 to 2 weeks) before the latest cases are reported to PHAC. This delay is a result of the time required to seek health care, get tested and receive results. It also takes time for public health authorities to gather information on cases. We update this information as it becomes available.
Figure 3. COVID-19 cases (n= Footnote 1 ) in Canada by date Footnote 2 as of ( )
Figure 3. COVID-19 cases (n= Footnote 1 ) in Canada by date Footnote 2 as of (total cases)
Figure 3. COVID-19 cases (n= Footnote 1 ) in Canada by date Footnote 2 as of (by age - 10 year groups)
Figure 3. COVID-19 cases (n= Footnote 1 ) in Canada by date Footnote 2 as of (by age - 20 year groups)
Figure 3: Text description
| Date Footnote 2 | 0-11 | 12-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60-69 | 70-79 | 80+ |
|---|
| Date Footnote 2 | 0-19 | 20-39 | 40-59 | 60-79 | 80+ |
|---|
Demographics
We have detailed case report data from 99,853 cases. We know the age of patients in 99.78 % of cases, and both age and gender in 99.98 % of cases.
Of the cases reported in Canada so far, {Percent Gender} were {Gender} and {Percent of Over 60} were between 20 and 39 years old (Figure 4).
Figure 4.
Figure 4: Text description
| Age group (years) | Number of cases with case reports (percentage) | Number of male cases (percentage) | Number of female cases (percentage) | Number of other cases (percentage) |
|---|
Cases following vaccination
Data extracted on for cases between December 14, 2020 and .
Changes to update schedule
We’ve adjusted our update schedule to reflect changes in how often this data is reported to us.
- “Cases following vaccination rate ratio indicators” are updated every 4 weeks.
- “Case counts” and “distributions of cases following vaccination” are updated weekly.
While COVID-19 vaccines are highly effective at preventing severe outcomes such as hospitalization and death, vaccinated people can still get infected if exposed. This means that even with high vaccine effectiveness, some vaccinated people will get sick, be hospitalized or die.
Most people in Canada have been vaccinated . Because they’re a larger group, there will naturally be more cases among vaccinated people than among unvaccinated people. However, despite their higher case counts, vaccinated people are less likely to get very sick or die .
Case counts underestimate the total number of COVID-19 cases because a rapid increase in cases starting in December 2021 led to changes in COVID-19 testing policies and delays in data entry.
Case counts are likely to over-represent people at risk of severe disease, because they have been prioritized for testing. Data should be interpreted with caution.
Cases reported since the start of the vaccination campaign, as of July 03, 2021
The vaccination campaign began on December 14, 2020. Since then, we've received case-level vaccine history data for 75.5 % (n= 624,980 ) of known COVID-19 cases aged 5 and older.
Of these cases:
- ( ) were unvaccinated
- ( ) were fully vaccinated
- ( ) were fully vaccinated with 1 additional dose
- ( ) were fully vaccinated with 2 or more additional doses
For definitions of the different vaccine statuses, please refer to the Technical notes and definitions section .
Figure 5. of confirmed COVID-19 cases reported to PHAC by vaccination status as of July 10, 2021
Figure 5: Text description
| Status | Cases | Hospitalizations | Deaths |
|---|
July 10, 2021 .
Cases following vaccination were more common among older adults and females (Table 2). This may be due to:
- higher risk of disease among older adults and pregnant people
- longer life expectancy among females, which means more women move into older age groups with a higher risk of disease
Older adults have been prioritized for second booster doses. As a result, older people make up a large proportion of people who have been fully vaccinated with 2 or more additional doses. For the same reason, they also make up a large proportion of cases in that group.
- Source : Detailed case information received by PHAC from provinces and territories, since December 14, 2020 (see data notes in the Technical notes and definitions section )
Fully vaccinated people diagnosed with COVID-19 were significantly less likely to be hospitalized or to die, particularly if they received an additional dose(s).
Between and , unvaccinated cases were times more likely to be hospitalized and times more likely to die from their illness, compared to fully vaccinated cases. During the same 4-week period, unvaccinated cases were times more likely to be hospitalized and times more likely to die from their illness, compared to cases fully vaccinated with 1 or more additional doses ( see data notes in Technical notes and definitions section ).
Technical notes and definitions
Data for this analysis comes from the COVID-19 national data set, which contains detailed case-level information received by PHAC from all provinces and territories.
Data notes for Table 2
- 12 of 13 provinces and territories have reported case-level vaccine history data to PHAC as part of the national COVID-19 dataset.
- of these provinces and territories reported data on cases fully vaccinated with 1 additional dose. of the 12 provinces and territories reported data on cases fully vaccinated with 2 or more additional doses. In provinces and territories that have not yet reported additional dose data, cases are classified as fully vaccinated if they are either fully vaccinated or fully vaccinated with 1 or more additional doses.
- We used a data cut-off of to account for routine reporting delays associated with vaccine history information.
- Data presented here on cases fully vaccinated with 1 or more additional dose(s) are limited to individuals aged 12 years or older. Eligibility for booster dose programs varies across provinces and territories.
- * When available, we used gender data. If unavailable, we used sex data. We excluded cases with missing gender and sex data from the gender analysis. Reliable data on gender diverse respondents are unavailable due to small counts.
- † Counts of cases by vaccine status may not add up to total counts, as data on cases not yet protected and partially vaccinated cases are not presented here.
Data notes for 4-week age standardized rate ratios
- Rate ratios are age-standardized using July 2021 Canadian population estimates.
- For analyses of rate ratios, cases are classified as fully vaccinated with one or more additional dose(s) if they have received at least 1 additional dose following the receipt of a primary series (fully vaccinated).
- Rate ratio calculations were based on data from provinces and territories that have reported complete case-level vaccine history data to PHAC during the 4-week period of analysis.
Vaccine status definitions
Episode date : Refers to symptom onset date. When symptom onset date is unavailable or the case is asymptomatic, episode date refers to either:
- laboratory specimen collection date, or
- laboratory testing date
PHAC monitors cases following vaccination using the following categories:
- Unvaccinated cases : those who were unvaccinated at the time of their episode date.
- Cases not yet protected from vaccination : those whose episode date occurred less than 14 days after their first dose of the vaccine.
-
Partially vaccinated cases
: those whose episode date occurred:
- 14 days or more after their first vaccine dose in a 2-dose series, or
- less than 14 days after their second dose of the vaccine.
-
Fully vaccinated cases
: those whose episode date occurred:
- 14 days or more after receipt of a second dose in a 2-dose series, or
- 14 days or more after receipt of one dose of a 1-dose vaccine series, and
- if an additional (for example, third dose or booster) dose was received, 0 to <14 days after receipt of the additional dose.
-
Fully vaccinated cases with 1 or more additional dose(s)
: those whose episode date occurred 14 days or more following the receipt of at least 1 additional dose (for example, third dose or booster) of a COVID-19 vaccine product, after being fully vaccinated.
-
Data on counts and distributions are further categorized into 2 groups:
- Fully vaccinated with 1 additional dose cases : those whose episode date occurred 14 days or more following receipt of 1 additional dose (for example, third dose or first booster) of a COVID-19 vaccine product and, if a second additional dose was received, 0 to <14 days after receipt of that dose
- Fully vaccinated with 2 or more additional doses cases : those whose episode date occurred 14 days or more following receipt of at least two additional doses (for example, fourth dose or second booster)
-
Data on counts and distributions are further categorized into 2 groups:
- COVID-19 vaccine product : vaccines that have been:
Severe illness and outcomes
Hospital use
Figure 6. Daily number of hospital beds and ICU beds occupied by COVID-19 patients as of
Download hospitalization, ICU and mechnical ventilation data in .csv formatFigure 6: Text description
| Date | Total patients hospitalized | Patients hospitalized in non-ICU | Patients in the ICU | Patients who were mechanically vented |
|---|
Between October 10 and Oct 17 :
- the total number of hospital beds occupied by COVID-19 patients increased from to beds.
- the number of non-ICU beds occupied by COVID-19 patients increased from to beds.
- the number of ICU beds occupied by COVID-19 patients increased from to beds.
- the number of COVID-19 patients who were mechanically vented increased from to .
Hospitalizations and deaths to date
We have detailed case report data on 99,853 cases, and hospitalization status for 65,597 ( xx %) of them:
- {Num Hospitalized} cases ( {Percent Hospitalized} %) were hospitalized, of whom:
- {Num Intensive Care} ( {Percent Intensive Care} %) were admitted to the ICU
The provinces and territories provided detailed case report forms for {Num Deaths} deaths related to COVID-19.
Figure 7. Age and gender Footnote 3 distribution of COVID-19 cases in Canada as of (n= Footnote 1 )
Figure 7a. Age and gender Footnote 3 distribution of COVID-19 cases hospitalized in Canada as of (n= Footnote 1 )
Figure 7b. Age and gender Footnote 3 distribution of COVID-19 cases admitted to ICU in Canada as of (n= Footnote 1 )
Figure 7c. Age and gender Footnote 3 distribution of COVID-19 cases deceased in Canada as of (n= Footnote 1 )
Data note: Figure 7 includes COVID-19 cases hospitalized, admitted to ICU, and deceased for which age and gender information were available. Therefore, some COVID-19 hospitalizations, ICU admissions, and deaths may not be included in Figure 7.
Figure 7: Text description
| Age group (years) | Number of cases with case reports (percentage) | Number of male cases (percentage) | Number of female cases (percentage) | Number of other cases (percentage) |
|---|
| Age group (years) | Number of cases with case reports (percentage) | Number of male cases (percentage) | Number of female cases (percentage) | Number of other cases (percentage) |
|---|
| Age group (years) | Number of cases with case reports (percentage) | Number of male cases (percentage) | Number of female cases (percentage) | Number of other cases (percentage) |
|---|
Provincial, territorial and international reporting
For more information, please refer to provincial or territorial COVID-19 webpages:
- British Columbia
- Alberta
- Saskatchewan
- Manitoba
- Ontario
- Quebec
- Newfoundland and Labrador
- New Brunswick
- Nova Scotia
- Prince Edward Island
- Yukon
- Northwest Territories
- Nunavut
- World Health Organization
- Centers for Disease Control and Prevention
- European Centre for Disease Control and Prevention